5-Methyltryptophan-resistant mutants derived from Bacillus subtilis strain 168 synthesize all of the tryptophan biosynthetic enzymes constitutively and excrete tryptophan. These mutants can be divided into three classes: class 1, low enzyme level and low rate of tryptophan excretion; class 2, high enzyme level and intermediate rate of tryptophan excretion; and class 3, high enzyme level and high rate of tryptophan excretion. A bradytrophic requirement for phenylalanine is correlated with the rate of tryptophan excretion. The phenylalanine requirement is relieved when the rate of tryptophan excretion is reduced by either (i) lowering the level of the tryptophan enzymes, (ii) reducing the supply of a tryptophan precursor (chorismate), or (iii) stopping tryptophan synthesis by a mutational block in the pathway. All of the mutants map in a region of the chromosome previously reported as the mtr locus. Our data show that synthesis of the tryptophan enzymes is controlled through the mtr locus but not influenced by precursors of tryptophan.
The tryptophan analogue, 5-methyltryptophan, inhibits the growth of wild-type strains of Bacillus subtilis. At high concentrations the analogue may affect cell growth by at least three mechanisms: (i) false repression of the tryptophan biosynthetic enzymes, (ii) false feedback inhibition of anthranilate synthase, (iii) production of faulty proteins by replacement of tryptophan. Resistance to methyltryptophan results from several classes of mutations in Escherichia coli. One class is the regulator (trpR) gene mutation which results in the change of a protein assumed to be the classical regulator protein (2, 11) . TrpR gene mutations result in constitutive synthesis of the tryptophan enzymes and resistance to high concentrations of 5-methyltryptophan. A second class contains the operator-constitutive mutants which produce partially constitutive levels of the tryptophan enzymes (4) . A third class of methyltryptophan-resistant mutants has been described with an altered anthranilate synthase which is no longer feedback inhibited by tryptophan or methyltryptophan (12, 16) . Permease mutants which exclude entry of the analogue into the cell would be expected as a fourth class of 5-methyltryptophan-resistant mutants (H. S. Moyed 5-methyltryptophan. Mutations in this locus caused constitutive synthesis of the tryptophan enzymes at high levels. The methyltryptophan resistance (mtr) locus is genetically linked to the tryptophan gene cluster but is not a part of any of the tryptophan structural genes. The mtr gene has been assumed to be equivalent to the trpR gene in E. coli. Whitt and Carlton (18) studied a number of 5-methyltryptophan-resistant strains of B. subtilis and concluded that there are several categories of resistant strains. They reported strains that differed in enzyme level and repressibility of the tryptophan biosynthetic enzymes. Linkage to the first tryptophan gene (trpE) was reported to vary between 1 and 60% in two-point transformation crosses, but no correlation was observed between the degree of linkage and the regulatory effect of the mutation,
The present report is concerned with nutri- ' Values are expressed as nanomoles per Klett unit per hour; the excretion (E) was divided by the average doubling time in hours of the culture under the conditions of the experiment.
WB3159 is typical of several mtr strains that were selected on plates containing 5-methyltryptophan and phenylalanine. All these strains require phenylalanine for optimal growth.
Tryptophan at high concentrations is known to inhibit the growth of wild-type strains of B. subtilis (6, 13) . The probable reason for this inhibition is that tryptophan is a potent inhibitor of the phenylalanine biosynthetic enzyme prephenate dehydratase (13, 1 5a). One explanation of the phenylalanine bradytrophism (partial requirement) of our mtr strains is that their over-production of tryptophan inhibits phenylalanine synthesis. This scheme would predict a relationship between the amount of tryptophan excreted and the degree of stimulation by phenylalanine. Figure I shows the time course of tryptophan excretion by representatives of several types of mtr mutants. Since all of the cultures were grown in minimal medium supplemented with 50 gg of phenylalanine/mI, their growth rates are essentially equal. The results agree with the prediction that the strains growing more slowly without phenylalanine excrete more tryptophan, e.g., strain WB3164 excretes the most tryptophan and has the greatest requirement for phenylalanine ( Table 2) .
By plotting the amount of tryptophan excreted per milliliter of medium against the cell density, a straight line is obtained when the cells are in the logarithmic state of growth. The slope of this line (E) is proportional to the amount of tryptophan excreted by each cell. The constant E was determined for each of the mutants and is listed in Table 2 . In examining these values for E, it is apparent that the level of excretion of tryptophan is decreased when phenylalanine is added to the medium. This effect is accounted for when the growth rate is considered. The constant E tells us the amount of tryptophan excreted when the culture goes from mass1 to mass2 but does not consider the time required for this increase in mass. If two growing cells excrete tryptophan at the same rate per unit of time, they will excrete different amounts of tryptophan while doubling in mass if one grows more rapidly than the other. To correct for differences in growth rate we divided E by the doubling time to get a specific rate of excretion (Q). The Q values are essentially the same for a given strain growing with or without phenylalanine and vary from strain to strain according to the amount of growth stimulation seen when phenylalanine is added to the medium. We conclude from these data that the specific rate of tryptophan excretion is a physiological characteristic of the strain and the rate of excretion is related to the restriction of growth of these mir strains in However, it seemed possible that these mutants, although constitutive for the tryptophan biosynthetic enzymes, could differ significantly in the actual level of enzyme production. Each type of mtr mutant that we have examined is represented in Table 3 . The enzyme levels of a prototroph growing in minimal medium without tryptophan are given for comparative purposes; these levels approach the lower limits of our enzyme assays. Strain GSY264 appears to occupy a class by itself, having enzyme levels approximately three-to sixfold lower than the average of the other mutants. All of the other mutants can be considered to have comparable enzyme levels. Elevated InGPS levels seen in WB746, WB3160, and WB3164 have been observed previously in several tryptophan auxotrophs (5) and cannot be considered unique to certain classes of mtr mutants. Although all of the mutants are derived from strain 168, their histories are so varied that the fluctuations observed among the remaining four activities cannot be considered significant. What does appear most significant is the marked elevation of these four specific activities above the prototrophic levels.
Chorismate excretion. Chorismate is the branch point compound in the synthesis of phenylalanine, tyrosine, and tryptophan. Thus it may play an important role in determining the amount of tryptophan produced. To examine the amount of chorismate available to the cell we measured the amount of chorismate excreted. Table 4 shows the results of these experiments. These data point out one important fact. All of the strains which contain the "low" activity chorismate mutase, CM., excrete approximately 30 to 50 times more chorismate than strain WB3166 containing the "high" activity chorismate mutase, CM1.
Phenylalanine requirement. Our working hypothesis is that the phenylalanine requirement is the result of tryptophan inhibition of phenylalanine synthesis since greater rates of tryptophan excretion accompany greater requirements for phenylalanine. We felt that the hypothesis could be tested in two other ways. The phenylalanine requirement should be overcome either by blocking the synthesis of tryptophan or by decreasing the amount of chorismate available for tryptophan synthesis.
When the growth rate of strain BS71 containing the mir-222 locus and a trpE block was meas- 10 Ag of tryptophan per ml and 20 Mg of phenylalanine (for GSY222, WB3160 and WB3164) per ml. Cells were harvested, and the cells to be used for the glycerol extract were washed twice in 10 ml 0.1 M potassium phosphate (pH 7.8) containing 15% (v/v) glycerol. The appropriate glycerol and sucrose extracts were then made as described in Materials and Methods. The addition of CM1 to the phenylalanine bradytrophic strain, therefore, eliminates the requirement for phenylalanine. Table 2 shows that such a strain excretes tryptophan at approximately 1/40 the rate of its sister strain carrying only the low level chorismate mutase, CM,. Thus, this strain acts essentially like the wild type with respect to tryptophan excretion but has high levels of the tryptophan enzymes produced constitutively and is resistant to 5-methyltryptophan. This experiment does not prove that CM1 overcomes phenylalanine bradytrophy simply by reducing the supply of chorismate available for tryptophan biosynthesis. The experiment does show, however, that when the level of chorismate is reduced, the regulation of tryptophan synthesis is returned to normal. This fact indicates that the extreme over-production of tryptophan is not the result of a secondary alteration of the tryptophan enzymes but the mtr mutation. Indeed, we believe that no alteration of the kinetic properties of anthranilate synthase is required to explain the great over-production of tryptophan observed.
Induction of the tryptophan enzymes. Kane and Jensen (7) have postulated that the most critical factor regulating the synthesis of tryptophan enzymes in B. subtilis is not the level of tryptophan but rather the level of chorismate. In correlating the production of the tryptophan enzymes with the amount of chorismate excreted in these mtr strains, we find no evidence for chorismate as the obligatory inducer, in the presence or absence of tryptophan. Consider first the two mtr strains, WB3164 and WB3166, which differ only in their level of chorismate mutase. Strain WB3166 contains the "high" chorismate mutase, CM,; there is little chorismate accumulated (0.04 to 0.08 nmoles/ml). Nevertheless, the levels of the tryptophan biosynthetic enzymes (see Table 3 ) are comparable to those of strain WB3 164 which accumulates considerably more chorismate (2.2 to 4.4 nmoles/ml). The reverse situation is also apparent in another mtr strain; GSY264 does not contain enzyme levels equal to those of other strains accumulating comparable amounts of chorismate. Strain NP 100, which was used by Kane and Jensen (7) to substantiate their chorismate induction hypothesis, was characterized by us as a class 3 mutant similar to WB3164 (S. 0. Hoch and C. W. Roth, unpublished data). Furthermore, it maps at the mtr locus (see Table 6 ).
We pursued this investigation further as it is crucial to an understanding of the actual control pattern operating in B. subilis. We first introduced an aroB (dehydroquinate synthase) block into a trpE (AS-) mutant. Because of the aroB block this strain will not make any chorismate unless shikimate is supplied in the growth media. When shikimate is supplied, the anthranilate synthase block prevents any depletion of the chorismate pool in the direction of tryptophan production. Lorence and Nester (9) reported that both "high" and "low" chorismate mutase species would be partially repressed when B. subtilis is grown in the presence of an excess of the three aromatic amino acids. The results of several experiments with this aroB-trpE-mutant (BS66) are shown in Table 5 . In the presence of I ug of tryptophan per ml, the mutant is maximally derepressed whether or not shikimate is supplied to the growth media. In the presence of 10 jig of tryptophan per ml, the mutant appears maximally repressed even when shikimate is supplied. If chorismate does function as an inducer, there should be at least partial relief of the tryptophan repressive effect; no relief is seen.
Since the amount of chorismate accumulated in the aroB-trpE-strain was dependent on the cells' uptake of the intermediate, shikimate, we decided to repeat the "induction" experiment by using a mutant in which synthesis of chorismate could be controlled by merely controlling the synthesis of 3-deoxy-D-arabino-heptulosonic acid-7-phosphate (DAHP) synthase. We used strain WBIOOO which contains a triple block in AS, prephenate dehydratase, and prephenate dehydrogenase. The level of DAHP synthase is primarily under the control of tyrosine (14) . The results are essentially the same as the previous experiment. At high tyrosine and tryptophan concentrations, the tryptophan enzymes are repressed. At low tyrosine and high tryptophan concentrations, there is no relief of the repression. Again there is no evidence of even partial relief.
Mapping. The mapping results based on twofactor transformation crosses are shown in Table  6 . Within the limits of the method, all of the mtr mutants appear to occupy one locus, and this locus appears to be identical with the mtr locus first reported by Nester et al. (15) . Its The phenylalanine requirement of the mtr strains is directly related to the level of tryptophan excretion. We quantitated this requirement by measuring the difference in growth rate of several strains in minimal medium with and without added phenylalanine. The phenylalanine supplement is sufficient in each case to restore the growth rate to the prototrophic level. As the specific rate of tryptophan excretion (Q) increases, the difference in growth rate increases proportionately. The tryptophan effect can be attributed to its role as a potent feedback inhibitor of the branch point enzyme, prephenate dehydratase, leading to phenylalanine biosynthesis (13) . This hypothesis is supported by the finding that methionine, a known activator of prephenate dehydratase and antagonist of the tryptophan inhibition of this enzyme (1 5a), almost completely relieves the growth rate inhibition seen with high tryptophan concentrations in minimal media. Strain WB3159, a high tryptophan excretor, had a growth rate in minimal medium plus methionine (50ug/ml) equivalent to 90% of its growth rate in the same medium plus phenylalanine (50 gg/ml) (C. W. Roth, unpublished observations). It is still not entirely clear what additional factors determine exactly how much tryptophan is produced in these mtr strains. Certainly the level of the biosynthetic enzymes will affect tryptophan production. GSY264 which contains the lowest level of enzymes produces the least tryptophan. The availability of chorismate as substrate could also affect the amount of tryptophan produced. Possible instability of chorismate during our extraction procedure led us to place greatest significance on the large differences in accumulation between strains containing the high and low activity chorismate mutases. By our method we would not necessarily be able to detect small differences in intracellular chorismate levels between two classes of mtr mutants, as between class 2 and 3. In these two classes, there are no significant differences in tryptophan enzyme levels, so a twofold difference in chorismate availability could result in the observed twofold difference in tryptophan excretion. Such a difference in the chorismate pool could perhaps be explained by small differences in the activity of chorismate mutase in these two classes. Similarly, the amount of tyrosine produced could affect the level of the chorismate pool. If in fact more chorismate is being channelled to tyrosine in class 2 compared to class 3 mutants, the chorismate pool would be depleted.
We were also interested in chorismate pool levels because of the hypothesis that chorismate is the inducer of the tryptophan biosynthetic enzymes (7 Mutations in the mtr locus are resistant to fluorotryptophan even when tryptophan synthesis is blocked genetically. This finding suggests that resistance is not the simple result of diluting the analogue with endogenous tryptophan. These results could be explained if the mutation affects tryptophan utilization in some manner. An alternative explanation is that the mtr mutation has a pleiotropic effect which causes the production of a substance other than tryptophan which can reverse the growth inhibition by the tryptophan analogues. Experiments to determine the nature and mode of action of the mtr locus are now in progress.
